Author

A. Sanlaville

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

C. Caux· 2 shared J. Valladeau-Guilemond· 2 shared N. Bendriss-Vermare· 2 shared A. Puisieux· 1 shared A. Voissiere· 1 shared C. Brousse· 1 shared C. Perret· 1 shared D. Poujol· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. Caux

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CD4 T cells and neutrophils contribute to epithelial-mesenchymal transition in breast cancer

A. Sanlaville, A. Voissiere, D. Poujol, M. Hubert, S. Andre, C. Perret, J.-P. Foy, N. Goutagny, M. Malfroy, I. Durand, M. Chalons, J. Valladeau-Guilemond, P. Saintigny, A. Puisieux, C. Caux, , N. Bendriss-Vermare

The paper shows CD4 T cells and neutrophils promote EMT in breast cancer by analyzing murine tumor models and human cohorts.

bioRxiv · Feb 15, 2023 · PreprintCancer Biology

cDC1 and interferons promote spontaneous CD4+ and CD8+ T cell protective responses to breast cancer

R. Mattiuz, C. Brousse, M. Ambrosini, J.-C. Cancel, G. Bessou, J. Mussard, A. Sanlaville, C. Caux, N. Bendriss-Vermare, J. Valladeau-Guilemond, M. Dalod, K. Crozat

This study shows that cDC1 and interferons are critical for CD4+ and CD8+ T cell responses against breast cancer, promoting infiltration and effector functions, and improving patient prognosis.

bioRxiv · Dec 23, 2020Immunology